The problem with reactive healthcare

Most people enter healthcare through the same kind of door, and it is always marked with a reason. A symptom that would not settle. A result that came back flagged. A referral, a scan, a name for something that did not have one a week ago. We arrive because something has already gone wrong, and the system, to its great credit, knows exactly what to do next.

But notice the timing. By the moment that door opens, the most useful window has usually already closed. The years in which the outcome was most changeable, the long, ordinary stretch of unremarkable days, passed without anyone watching them. Not because anyone was careless, but because there was no one whose job it was to look.

This is not a story about personal failure, and it is worth saying so plainly before anything else. You did not miss something you were supposed to catch. You are using a system that was designed to begin at the point of crisis, and it begins there reliably and well. This article is about the design itself: why healthcare waits, what the waiting costs, and what it would mean to move the starting line somewhere earlier.

There is a quiet asymmetry worth sitting with. Most of what shapes long-term health is decided in ordinary days, in sleep, in stress, in the slow drift of a blood pressure or a resting heart rate over years. Yet almost all of the system’s attention arrives only after a diagnosis, once those ordinary days have already done their work. The most consequential period of your health is also the period the system is least equipped to see.

Reactive by design, not by accident

Modern medicine has genuine, hard-won strengths. Emergency response is one of the great achievements of the last century, and acute treatment, surgical intervention, and the management of a crisis once it has arrived are extraordinary. Nothing here is an argument against them.

But look closely at what those strengths have in common. Every one of them describes a system optimised for the moment after something goes wrong. The architecture rewards diagnosis, because a diagnosis is where treatment can begin. It is organised around episodes: the visit, the procedure, the follow-up, discrete events with a clear start and a clear end.

What the structure has very little of is a mechanism for the long middle. The years between episodes, where health is quietly being decided, are not anyone’s department. There is no appointment for a trend, no billing code for a direction of travel. The system is not built to watch, it is built to respond, and a system built to respond will, by definition, wait until there is something to respond to.

This matters because “reactive” can sound like an accusation, and it is not meant as one. Reactive is simply an accurate description of where a system’s centre of gravity sits. The instinct to call a doctor when something is wrong is correct. The problem is that, for most people, calling when something is wrong is the only mode of contact the system offers. There is no equivalent default for the years when nothing is obviously wrong but a great deal is quietly being decided. The result is a relationship with healthcare that is, by design, almost entirely about its worst days.

Follow the money: where the system spends its attention

If you want to understand what a system truly values, look at where it spends.

Around 90% of the United States’ annual health-care expenditure, a total of $4.9 trillion, goes to people with chronic and mental-health conditions (Source: CDC, Fast Facts: Health and Economic Costs of Chronic Conditions, 2025). That is not a criticism of how the money is used; people living with established conditions need that care. But it tells you, with great clarity, where the system’s attention sits: overwhelmingly downstream, on managing disease that has already taken hold.

Now look upstream. Preventive care accounted for just 2.9% of total US health expenditure in 2018, down from 3.7% in 2000 (Source: Peterson-KFF Health System Tracker, public-health and prevention spending analysis, 2018 data). Prevention is not only a small share of the whole, that share has been quietly shrinking. The pattern is not unique to the United States. Across the OECD, prevention averages roughly 3.4% of total health expenditure (Source: OECD, Health at a Glance 2025, 2023 data).

A system that directs almost everything toward managing established disease, and a few cents in the dollar toward preventing it, is not a careless system. It is a consistent one, doing precisely what its design asks of it. It is waiting.

The cost of waiting is mostly preventable

It would be easy here to reach for fear. We will not, because fear is not the point. Leverage is.

Noncommunicable diseases, the chronic conditions, caused at least 43 million deaths in 2021, about 75% of all non-pandemic deaths worldwide (Source: WHO, Noncommunicable Diseases fact sheet, 2021 data, updated 2024). In the WHO European Region, those conditions account for an estimated 1.8 million avoidable deaths each year and cost some US$514 billion annually, and about 60% of those avoidable deaths are linked to preventable causes (Source: WHO/Europe, 2025).

Read that word again: preventable. It matters not because it is alarming, but because it is hopeful. A burden tied to modifiable factors is, in principle, a burden that can be reached earlier. The knowledge of what helps largely exists. What has been missing is not the science but the timing: a way for that knowledge to arrive while it can still change the story, rather than after the story has been written.

The scale of the missed opportunity is matched by the scale of the spending it produces. US national health spending reached $5.3 trillion in 2024, about 18% of GDP, and grew 7.2% year on year, a rise driven largely by treatment and utilisation rather than prevention (Source: CMS / Health Affairs, National Health Expenditure data, 2024). Individual risk factors carry costs that are almost difficult to picture: physical inactivity alone costs the US health system about $192 billion a year (Source: CDC, 2025). These are not abstractions. They are the price of a starting line drawn late, and the size of the prize for drawing it earlier.

What “earlier” actually means

It is worth being precise about what moving the starting line does and does not mean, because the phrase can sound exhausting.

Earlier does not mean constant testing. It does not mean living inside a clinic, or treating every ordinary fluctuation as a warning. That would simply be anxiety with a schedule, and anxiety is not health.

Earlier means continuity of attention. It means the long middle, the part the system currently leaves unwatched, has something calmly and patiently keeping an eye on its direction. The difference between reactive and proactive care is rarely about better information; it is about the same information, read sooner. A single reading is a moment in isolation. A trend is a story. Watch the direction, not the dot. Reactive care is structurally limited to the dot, because it only sees you at the appointment. The line, the thing that actually tells you where you are heading, is the part no one has been positioned to read.

Why the gap has been so hard to close

If earlier is so obviously better, why has the system not simply moved? Because prevention has always been genuinely hard to do.

It is hard to fund, because the payoff is diffuse and arrives years away, long after the budget cycle that would have paid for it. It is hard to measure, because success looks like an absence: the crisis that never came, the diagnosis that was never needed. And it has been hard to make personal, because general advice is not the same as guidance that knows your particular life, your particular patterns, your particular history.

There has also been a simpler practical gap. Two appointments a year, however good, cannot govern 365 days of health. Between those visits there has been no layer, nothing continuous, intelligent and personal holding the thread. That is a system-design problem, and the encouraging thing about system-design problems is that they can be solved with better infrastructure.

It is worth being honest about a tension at the heart of this. The same access constraints that make reactive care expensive also make proactive care harder to imagine: when an appointment is scarce and brief, the instinct is to save it for a real problem. That logic, sensible for the individual, is exactly what hardens the system’s reactive shape. The way out is not to ask people to seek more appointments. It is to build something that does not depend on an appointment at all: a continuous, low-friction layer that watches the direction so that the appointments, when they are needed, start from a much richer picture.

Moving the starting line

This is where AverCare begins. AverCare exists to move the starting line of care earlier, from treatment toward prevention, by becoming the layer the system has never had.

It is an intelligent, always-on health platform: one calm layer of intelligence between your data and your decisions. It connects continuous signals from connected wearables, an AI companion called Aver, and clinically governed guidance into a single system that watches the long middle, not just the crisis. It does not replace the care you already have, and it is not trying to. It complements that care, holding the ordinary in-between days the system was never built to see, and noticing direction long before anything becomes a diagnosis.

AverCare is pre-launch. If a calmer, earlier way of looking after your health is something you have quietly wanted, you can be among the first to it. Join the waitlist, and follow along.